Home
Phenotypic Mutations
Incidental Mutations
Engineered Mutations
Candidate Explorer
Protocols
Mutation Statistics
About
Contact
Links
Request Mice
Beutler Lab
APN
Strains @ MMRRC
Search Phenotypes
NEW
Candidate Explorer
Staff Login
Download
Phenotypic Mutations
22
mutations affecting
19
genes are currently displayed.
Mutations Mapped and Identified Based on Phenotype
[records 1 to 22 of 22]
10
25
50
100
500
1000
per page
Full List
Export
Source
UTSW
APN
Gene
E Score
~
Allele
Chr
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
X
Y
Chr Loc
Coordinate
Mode of Inheritance
Unknown
Autosomal Codominant
Autosomal Dominant
Autosomal Recessive
Autosomal Semidominant
X-linked Recessive
X-linked Dominant
Verification Probability
≥ 90%
≥ 80%
≥ 70%
≥ 60%
≥ 50%
≥ 40%
≥ 30%
≥ 20%
≥ 10%
≥ 0%
< 10%
< 20%
< 30%
< 40%
< 50%
< 60%
< 70%
< 80%
< 90%
No ML probability
Failed Initial Filter
OR is public
OR is verified
Updated
Phenotypic Category
all of
any of
125-03 Response - decreased
125-03 Response - increased
30 min GTT hyperglycemic
30 min GTT hyperglycemic (male)
30 min GTT hyperoglycemic (female)
30 min GTT hypoglycemic
30 min GTT hypoglycemic (female)
30 min GTT hypoglycemic (male)
adenovirus infection of macrophages - decreased
adenovirus infection of macrophages - increased
adipose tissue
anemia
Anophthalmia
Aut: Interaction - decreased
Aut: Interaction - increased
autoimmunity
behavior/neurological
Blood Analysis EO% - decreased
Blood Analysis EO% - increased
Blood Analysis Hb - decreased
Blood Analysis Hb - increased
Blood Analysis HCT - decreased
Blood Analysis HCT - increased
Blood Analysis LY# - decreased
Blood Analysis LY# - increased
Blood Analysis MCH - decreased
Blood Analysis MCH - increased
Blood Analysis MCHC - decreased
Blood Analysis MCHC - increased
Blood Analysis MCV - decreased
Blood Analysis MCV - increased
Blood Analysis MO# - decreased
Blood Analysis MO# - increased
Blood Analysis NE# - decreased
Blood Analysis NE# - increased
Blood Analysis Platelet Count - decreased
Blood Analysis Platelet Count - increased
Blood Analysis RBC - decreased
Blood Analysis RBC - increased
Blood Analysis RDW - decreased
Blood Analysis RDW - increased
Blood Analysis WBC - decreased
Blood Analysis WBC - increased
Blood Pressure: Pooled HR - decreased
Blood Pressure: Pooled HR - increased
Blood Pressure: Pooled SBP - decreased
Blood Pressure: Pooled SBP - increased
Body Weight - decreased
Body Weight - increased
Body Weight (BP, z-score, female) - decreased
Body Weight (BP, z-score, female) - increased
Body Weight (BP, z-score, male) - decreased
Body Weight (BP, z-score, male) - increased
Body Weight (DSS Female) - decreased
Body Weight (DSS Female) - increased
Body Weight (DSS Male) - decreased
Body Weight (DSS Male) - increased
Body Weight (DSS) - decreased
Body Weight (DSS) - increased
Body Weight (DSS, Day10) - decreased
Body Weight (DSS, Day10) - increased
Body Weight (DSS, Day7) - decreased
Body Weight (DSS, Day7) - increased
Body Weight (DSS, z-score) - decreased
Body Weight (DSS, z-score) - increased
Body Weight (DSS, z-score, female) - decreased
Body Weight (DSS, z-score, female) - increased
Body Weight (DSS, z-score, male) - decreased
Body Weight (DSS, z-score, male) - increased
Body Weight (Female) - decreased
Body Weight (Female) - increased
Body Weight (Male) - decreased
Body Weight (Male) - increased
Body Weight (Z-score) - decreased
Body Weight (Z-score) - increased
Body Weight (Z-score, female) - decreased
Body Weight (Z-score, female) - increased
Body Weight (Z-score, male) - decreased
Body Weight (Z-score, male) - increased
Bone: Femur Length (AI, residual) - decreased
Bone: Femur Length (AI, residual) - increased
Bone: Femur Length (AI, residual, female) - decreased
Bone: Femur Length (AI, residual, female) - increased
Bone: Femur Length (AI, residual, male) - decreased
Bone: Femur Length (AI, residual, male) - increased
Bone: Fore Hip Distance (AI) - decreased
Bone: Fore Hip Distance (AI) - increased
Bone: Fore Hip Distance (AI, female) - decreased
Bone: Fore Hip Distance (AI, female) - increased
Bone: Fore Hip Distance (AI, male) - decreased
Bone: Fore Hip Distance (AI, male) - increased
Bone: Hind Hip Distance (AI) - decreased
Bone: Hind Hip Distance (AI) - increased
Bone: Hind Hip Distance (AI, female) - decreased
Bone: Hind Hip Distance (AI, female) - increased
Bone: Hind Hip Distance (AI, male) - decreased
Bone: Hind Hip Distance (AI, male) - increased
Bone: Hip Ratio (AI) - decreased
Bone: Hip Ratio (AI) - increased
Bone: Pelvis Length (AI, residual) - decreased
Bone: Pelvis Length (AI, residual) - increased
Bone: Pelvis Length (AI, residual, female) - decreased
Bone: Pelvis Length (AI, residual, female) - increased
Bone: Pelvis Length (AI, residual, male) - decreased
Bone: Pelvis Length (AI, residual, male) - increased
Bone: Spine Deformity (female)
Bone: Spine Deformity (male)
Bone: Tibia Length (AI, residual) - decreased
Bone: Tibia Length (AI, residual) - increased
Bone: Tibia Length (AI, residual, female) - decreased
Bone: Tibia Length (AI, residual, female) - increased
Bone: Tibia Length (AI, residual, male) - decreased
Bone: Tibia Length (AI, residual, male) - increased
cardiovascular system
CD8 response - decreased
cellular phenotype
craniofacial
CTL killing - decreased
CTL killing - increased
CTL killing dominant epitope - decreased
CTL killing dominant epitope - increased
CTL killing subdominant epitope - decreased
CTL killing subdominant epitope - increased
digestive/alimentary
dsDNA Antibody - decreased
dsDNA Antibody - increased
dsDNA induced type I IFN production - decreased
dsDNA induced type I IFN production - increased
DSS: resistant
DSS: resistant day 10
DSS: resistant day 7
DSS: sensitive day 10
DSS: sensitive day 7
embryogenesis
endocrine/exocrine gland
extracellular cGAMP: high response
extracellular cGAMP: low response
eye: micro-ophthalmia
Eye: SL-OCT BM to ILM thickness - decreased
Eye: SL-OCT BM to ILM thickness - increased
Eye: SL-OCT BM to ILM thickness (base) - decreased
Eye: SL-OCT BM to ILM thickness (base) - increased
Eye: SL-OCT BM to ILM thickness (delta) - decreased
Eye: SL-OCT BM to ILM thickness (delta) - increased
Eye: SL-OCT INL to ILM thickness - decreased
Eye: SL-OCT INL to ILM thickness - increased
Eye: SL-OCT INL to ILM thickness (base) - decreased
Eye: SL-OCT INL to ILM thickness (base) - increased
Eye: SL-OCT INL to ILM thickness (delta) - decreased
Eye: SL-OCT INL to ILM thickness (delta) - increased
Eye: SL-OCT IPL to ILM thickness - decreased
Eye: SL-OCT IPL to ILM thickness - increased
Eye: SL-OCT IPL to ILM thickness (base) - decreased
Eye: SL-OCT IPL to ILM thickness (base) - increased
Eye: SL-OCT IPL to ILM thickness (delta) - decreased
Eye: SL-OCT IPL to ILM thickness (delta) - increased
FACS B cells - decreased
FACS B cells - increased
FACS B:T cells - decreased
FACS B:T cells - increased
FACS B1 cells - decreased
FACS B1 cells - increased
FACS B1a cells - decreased
FACS B1a cells - increased
FACS B1a cells in B1 cells - decreased
FACS B1a cells in B1 cells - increased
FACS B1b cells - decreased
FACS B1b cells - increased
FACS B1b cells in B1 cells - decreased
FACS B1b cells in B1 cells - increased
FACS B2 cells - decreased
FACS B2 cells - increased
FACS B220 MFI - decreased
FACS B220 MFI - increased
FACS CD11b+ DCs (gated in CD11c+ cells) - decreased
FACS CD11b+ DCs (gated in CD11c+ cells) - increased
FACS CD11c+ DCs - decreased
FACS CD11c+ DCs - increased
FACS CD4:CD8 - decreased
FACS CD4:CD8 - increased
FACS CD4+ T cells - decreased
FACS CD4+ T cells - increased
FACS CD4+ T cells in CD3+ T cells - decreased
FACS CD4+ T cells in CD3+ T cells - increased
FACS CD44+ CD4 MFI - decreased
FACS CD44+ CD4 MFI - increased
FACS CD44+ CD4 T cells - decreased
FACS CD44+ CD4 T cells - increased
FACS CD44+ CD8 MFI - decreased
FACS CD44+ CD8 MFI - increased
FACS CD44+ CD8 T cells - decreased
FACS CD44+ CD8 T cells - increased
FACS CD44+ T cells - decreased
FACS CD44+ T cells - increased
FACS CD44+ T MFI - decreased
FACS CD44+ T MFI - increased
FACS CD8+ T cells - decreased
FACS CD8+ T cells - increased
FACS CD8+ T cells in CD3+ T cells - decreased
FACS CD8+ T cells in CD3+ T cells - increased
FACS CD8a+ DCs (gated in CD11c+ cells) - decreased
FACS CD8a+ DCs (gated in CD11c+ cells) - increased
FACS central memory CD4 T cells in CD4 T cells - decreased
FACS central memory CD4 T cells in CD4 T cells - increased
FACS central memory CD8 T cells in CD8 T cells - decreased
FACS central memory CD8 T cells in CD8 T cells - increased
FACS effector memory CD4 T cells in CD4 T cells - decreased
FACS effector memory CD4 T cells in CD4 T cells - increased
FACS effector memory CD8 T cells in CD8 T cells - decreased
FACS effector memory CD8 T cells in CD8 T cells - increased
FACS effector T cells - decreased
FACS effector T cells - increased
FACS IgD MFI - decreased
FACS IgD MFI - increased
FACS IgD+ B cell percentage - decreased
FACS IgD+ B cell percentage - increased
FACS IgM MFI - decreased
FACS IgM MFI - increased
FACS IgM+ B cells - decreased
FACS IgM+ B cells - increased
FACS macrophages - decreased
FACS macrophages - increased
FACS memory T cells - decreased
FACS memory T cells - increased
FACS naive CD4 T cells in CD4 T cells - decreased
FACS naive CD4 T cells in CD4 T cells - increased
FACS naive CD8 T cells in CD8 T cells - decreased
FACS naive CD8 T cells in CD8 T cells - increased
FACS naive T cells - decreased
FACS naive T cells - increased
FACS neutrophils - decreased
FACS neutrophils - increased
FACS NK cells - decreased
FACS NK cells - increased
FACS NK1.1+ T cells - decreased
FACS NK1.1+ T cells - increased
FACS NKT cells (tet) - decreased
FACS NKT cells (tet) - increased
FACS pDCs - decreased
FACS pDCs - increased
FACS T cells - decreased
FACS T cells - increased
growth/size
hearing/vestibular/ear
hematopoietic competition - disadvantage
hematopoietic system
homeostasis/metabolism
IgA response to 2nd OVA/Alum Challenge (day 7) - decreased
IgA response to 2nd OVA/Alum Challenge (day 7) - increased
IgE response to a Cysteine Protease (Papain) - decreased
IgE response to a Cysteine Protease (Papain) - increased
IgG1 response to a Cysteine Protease (Papain) - decreased
IgG1 response to a Cysteine Protease (Papain) - increased
immune system
impaired response to dsDNA- type I IFN production by macrophages
inflammatory bowel disease phenotype
influenza proliferation in macrophages - decreased
influenza proliferation in macrophages - increased
influenza resistance
iron deficiency
iron excess
LCMV clone 13 resistance
lethality-embryonic/perinatal
lethality-postnatal
life span-post-weaning/aging
limbs/digits/tail phenotype
liver/biliary system
LPS Cachexia: Body Weight (day 0) - decreased
LPS Cachexia: Body Weight (day 0) - increased
LPS Cachexia: Body Weight (day 0, z-score) - decreased
LPS Cachexia: Body Weight (day 0, z-score) - increased
LPS Cachexia: Body Weight (day 1) - decreased
LPS Cachexia: Body Weight (day 1) - increased
LPS Cachexia: Body Weight (day 14) - decreased
LPS Cachexia: Body Weight (day 14) - increased
LPS Cachexia: Body Weight (day 2) - decreased
LPS Cachexia: Body Weight (day 2) - increased
LPS Cachexia: Body Weight Change (day 1, g) - decreased
LPS Cachexia: Body Weight Change (day 1, g) - increased
LPS Cachexia: Body Weight Change (day 1, ratio) - decreased
LPS Cachexia: Body Weight Change (day 1, ratio) - increased
LPS Cachexia: Body Weight Change (day 14, g) - decreased
LPS Cachexia: Body Weight Change (day 14, g) - increased
LPS Cachexia: Body Weight Change (day 14, ratio) - decreased
LPS Cachexia: Body Weight Change (day 14, ratio) - increased
LPS Cachexia: Body Weight Change (day 2, g) - decreased
LPS Cachexia: Body Weight Change (day 2, g) - increased
LPS Cachexia: Body Weight Change (day 2, ratio) - decreased
LPS Cachexia: Body Weight Change (day 2, ratio) - increased
LPS Hypersensitivity - decreased
LPS Hypersensitivity - increased
LPS-induced Necroptosis - decreased
LPS-induced Necroptosis - increased
Macrophage necroptosis: high
Macrophage necroptosis: low
MC38 tumor body weight change (%) - decreased
MC38 tumor body weight change (%) - increased
MC38 tumor body weight change (%, female) - decreased
MC38 tumor body weight change (%, female) - increased
MC38 tumor body weight change (%, male) - decreased
MC38 tumor body weight change (%, male) - increased
MC38 tumor body weight change (g) - decreased
MC38 tumor body weight change (g) - increased
MC38 tumor body weight change (g, female) - decreased
MC38 tumor body weight change (g, female) - increased
MC38 tumor body weight change (g, male) - decreased
MC38 tumor body weight change (g, male) - increased
MC38 tumor volume (day 22) - decreased
MC38 tumor volume (day 22) - increased
MC38 tumor volume (day 22, early sac sick or found dead, IM injection, dermatitis, trimmed) - decreased
MC38 tumor volume (day 22, early sac sick or found dead, IM injection, dermatitis, trimmed) - increased
MCMV proliferation in macrophages - decreased
MCMV proliferation in macrophages - increased
MCMV resistance
MCMV susceptibility
MTT dsDNA PECs - decreased
MTT dsDNA PECs - increased
MTT Value of PECs - decreased
MTT Value of PECs - increased
muscle
NALP3 inflammasome signaling defect
nervous system
NK cell response - decreased
NK killing - decreased
NK killing - increased
Nlrc4 inflammasome: high response
Nlrc4 inflammasome: low response
NLRP3 inflammasome: high response
NLRP3 inflammasome: low response
no phenotypic analysis
normal phenotype
other phenotype
OVA-specific IgE - decreased
OVA-specific IgE - increased
OVA-specific IgE after 2nd OVA/Alum - decreased
OVA-specific IgE after 2nd OVA/Alum - increased
Peritoneal exudates B1a cell % - decreased
Peritoneal exudates B1a cell % - increased
Peritoneal exudates B1a cell numbers - decreased
Peritoneal exudates B1a cell numbers - increased
Peritoneal exudates B1b cell % - decreased
Peritoneal exudates B1b cell % - increased
Peritoneal exudates B1b cell numbers - decreased
Peritoneal exudates B1b cell numbers - increased
Peritoneal exudates macrophage % - decreased
Peritoneal exudates macrophage % - increased
Peritoneal exudates macrophage numbers - decreased
Peritoneal exudates macrophage numbers - increased
Peritoneal exudates neutrophil % - decreased
Peritoneal exudates neutrophil % - increased
Peritoneal exudates neutrophil numbers - decreased
Peritoneal exudates neutrophil numbers - increased
phagocytosis in PECs - decreased
phagocytosis in PECs - increased
pigmentation
polycythemia
post-MCMV FACS B cells - decreased
post-MCMV FACS B cells - increased
post-MCMV FACS B:T cells - decreased
post-MCMV FACS B:T cells - increased
post-MCMV FACS B1 cells - decreased
post-MCMV FACS B1 cells - increased
post-MCMV FACS B1a cells - decreased
post-MCMV FACS B1a cells - increased
post-MCMV FACS B1a cells in B1 cells - decreased
post-MCMV FACS B1a cells in B1 cells - increased
post-MCMV FACS B1b cells - decreased
post-MCMV FACS B1b cells - increased
post-MCMV FACS B1b cells in B1 cells - decreased
post-MCMV FACS B1b cells in B1 cells - increased
post-MCMV FACS B2 cells - decreased
post-MCMV FACS B2 cells - increased
post-MCMV FACS B220 MFI - decreased
post-MCMV FACS B220 MFI - increased
post-MCMV FACS CD11b+ DCs (gated in CD11c+ cells) - decreased
post-MCMV FACS CD11b+ DCs (gated in CD11c+ cells) - increased
post-MCMV FACS CD11c+ DCs - decreased
post-MCMV FACS CD11c+ DCs - increased
post-MCMV FACS CD4:CD8 - decreased
post-MCMV FACS CD4:CD8 - increased
post-MCMV FACS CD4+ T cells - decreased
post-MCMV FACS CD4+ T cells - increased
post-MCMV FACS CD4+ T cells in CD3+ T cells - decreased
post-MCMV FACS CD4+ T cells in CD3+ T cells - increased
post-MCMV FACS CD44+ CD4 MFI - decreased
post-MCMV FACS CD44+ CD4 MFI - increased
post-MCMV FACS CD44+ CD4 T cells - decreased
post-MCMV FACS CD44+ CD4 T cells - increased
post-MCMV FACS CD44+ CD8 MFI - decreased
post-MCMV FACS CD44+ CD8 MFI - increased
post-MCMV FACS CD44+ CD8 T cells - decreased
post-MCMV FACS CD44+ CD8 T cells - increased
post-MCMV FACS CD44+ T cells - decreased
post-MCMV FACS CD44+ T cells - increased
post-MCMV FACS CD44+ T MFI - decreased
post-MCMV FACS CD44+ T MFI - increased
post-MCMV FACS CD8+ T cells - decreased
post-MCMV FACS CD8+ T cells - increased
post-MCMV FACS CD8+ T cells in CD3+ T cells - decreased
post-MCMV FACS CD8+ T cells in CD3+ T cells - increased
post-MCMV FACS CD8a+ DCs (gated in CD11c+ cells) - decreased
post-MCMV FACS CD8a+ DCs (gated in CD11c+ cells) - increased
post-MCMV FACS central memory CD4 T cells in CD4 T cells - decreased
post-MCMV FACS central memory CD4 T cells in CD4 T cells - increased
post-MCMV FACS central memory CD8 T cells in CD8 T cells - decreased
post-MCMV FACS central memory CD8 T cells in CD8 T cells - increased
post-MCMV FACS effector memory CD4 T cells in CD4 T cells - decreased
post-MCMV FACS effector memory CD4 T cells in CD4 T cells - increased
post-MCMV FACS effector memory CD8 T cells in CD8 T cells - decreased
post-MCMV FACS effector memory CD8 T cells in CD8 T cells - increased
post-MCMV FACS effector T cells - decreased
post-MCMV FACS effector T cells - increased
post-MCMV FACS IgD MFI - decreased
post-MCMV FACS IgD MFI - increased
post-MCMV FACS IgD+ B cell percentage - decreased
post-MCMV FACS IgD+ B cell percentage - increased
post-MCMV FACS IgM MFI - decreased
post-MCMV FACS IgM MFI - increased
post-MCMV FACS IgM+ B cells - decreased
post-MCMV FACS IgM+ B cells - increased
post-MCMV FACS macrophages - decreased
post-MCMV FACS macrophages - increased
post-MCMV FACS memory T cells - decreased
post-MCMV FACS memory T cells - increased
post-MCMV FACS naive CD4 T cells in CD4 T cells - decreased
post-MCMV FACS naive CD4 T cells in CD4 T cells - increased
post-MCMV FACS naive CD8 T cells in CD8 T cells - decreased
post-MCMV FACS naive CD8 T cells in CD8 T cells - increased
post-MCMV FACS naive T cells - decreased
post-MCMV FACS naive T cells - increased
post-MCMV FACS neutrophils - decreased
post-MCMV FACS neutrophils - increased
post-MCMV FACS NK cells - decreased
post-MCMV FACS NK cells - increased
post-MCMV FACS NK T cells - decreased
post-MCMV FACS NK T cells - increased
post-MCMV FACS NKT cells (tet) - decreased
post-MCMV FACS NKT cells (tet) - increased
post-MCMV FACS pDCs - decreased
post-MCMV FACS pDCs - increased
post-MCMV FACS T cells - decreased
post-MCMV FACS T cells - increased
ratio of OVA-specific IgE over the total IgE - decreased
ratio of OVA-specific IgE over the total IgE - increased
renal/urinary system
reproductive system
resistance to B10-F16 melanoma - decreased
resistance to B10-F16 melanoma - increased
respiratory system
response to injected CpG DNA - decreased
RVFV proliferation in macrophages - decreased
RVFV proliferation in macrophages - increased
RVFV susceptibility
secretory SlgA after 2nd OVA/Alum Challenge (day 7) - decreased
secretory SlgA after 2nd OVA/Alum Challenge (day 7) - increased
skeleton phenotype
skin/coat/nails
taste/olfaction
T-dependent humoral response defect- decreased antibody response to OVA+ alum immunization
T-dependent humoral response defect- decreased antibody response to rSFV
T-dependent humoral response defect- increased antibody response to OVA+ alum immunization
T-dependent humoral response defect- increased antibody response to rSFV
T-independent B cell response defect- decreased TNP-specific IgM to TNP-Ficoll immunization
T-independent B cell response defect- increased TNP-specific IgM to TNP-Ficoll immunization
TLR signaling defect: hypersensitivity to CpG + IFNg
TLR signaling defect: hypersensitivity to LPS
TLR signaling defect: hypersensitivity to MALP2
TLR signaling defect: hypersensitivity to PAM3CSK4
TLR signaling defect: hypersensitivity to poly I:C
TLR signaling defect: hypersensitivity to poly I:C + IFNg
TLR signaling defect: hypersensitivity to R848
TLR signaling defect: hyposensitivity to CpG + IFNg
TLR signaling defect: hyposensitivity to LPS
TLR signaling defect: hyposensitivity to MALP2
TLR signaling defect: hyposensitivity to PAM3CSK4
TLR signaling defect: hyposensitivity to poly I:C
TLR signaling defect: hyposensitivity to poly I:C + IFNg
TLR signaling defect: hyposensitivity to R848
TLR signaling defect: TNF production by macrophages
total IgE after 2nd OVA/Alum - decreased
total IgE after 2nd OVA/Alum - increased
Total IgE After 2nd OVA/Alum Challenge (day 7) - decreased
Total IgE After 2nd OVA/Alum Challenge (day 7) - increased
total IgE level - decreased
total IgE level - increased
touch/vibrissae
tumorigenesis
vision/eye
and
any of
none of
125-03 Response - decreased
125-03 Response - increased
30 min GTT hyperglycemic
30 min GTT hyperglycemic (male)
30 min GTT hyperoglycemic (female)
30 min GTT hypoglycemic
30 min GTT hypoglycemic (female)
30 min GTT hypoglycemic (male)
adenovirus infection of macrophages - decreased
adenovirus infection of macrophages - increased
adipose tissue
anemia
Anophthalmia
Aut: Interaction - decreased
Aut: Interaction - increased
autoimmunity
behavior/neurological
Blood Analysis EO% - decreased
Blood Analysis EO% - increased
Blood Analysis Hb - decreased
Blood Analysis Hb - increased
Blood Analysis HCT - decreased
Blood Analysis HCT - increased
Blood Analysis LY# - decreased
Blood Analysis LY# - increased
Blood Analysis MCH - decreased
Blood Analysis MCH - increased
Blood Analysis MCHC - decreased
Blood Analysis MCHC - increased
Blood Analysis MCV - decreased
Blood Analysis MCV - increased
Blood Analysis MO# - decreased
Blood Analysis MO# - increased
Blood Analysis NE# - decreased
Blood Analysis NE# - increased
Blood Analysis Platelet Count - decreased
Blood Analysis Platelet Count - increased
Blood Analysis RBC - decreased
Blood Analysis RBC - increased
Blood Analysis RDW - decreased
Blood Analysis RDW - increased
Blood Analysis WBC - decreased
Blood Analysis WBC - increased
Blood Pressure: Pooled HR - decreased
Blood Pressure: Pooled HR - increased
Blood Pressure: Pooled SBP - decreased
Blood Pressure: Pooled SBP - increased
Body Weight - decreased
Body Weight - increased
Body Weight (BP, z-score, female) - decreased
Body Weight (BP, z-score, female) - increased
Body Weight (BP, z-score, male) - decreased
Body Weight (BP, z-score, male) - increased
Body Weight (DSS Female) - decreased
Body Weight (DSS Female) - increased
Body Weight (DSS Male) - decreased
Body Weight (DSS Male) - increased
Body Weight (DSS) - decreased
Body Weight (DSS) - increased
Body Weight (DSS, Day10) - decreased
Body Weight (DSS, Day10) - increased
Body Weight (DSS, Day7) - decreased
Body Weight (DSS, Day7) - increased
Body Weight (DSS, z-score) - decreased
Body Weight (DSS, z-score) - increased
Body Weight (DSS, z-score, female) - decreased
Body Weight (DSS, z-score, female) - increased
Body Weight (DSS, z-score, male) - decreased
Body Weight (DSS, z-score, male) - increased
Body Weight (Female) - decreased
Body Weight (Female) - increased
Body Weight (Male) - decreased
Body Weight (Male) - increased
Body Weight (Z-score) - decreased
Body Weight (Z-score) - increased
Body Weight (Z-score, female) - decreased
Body Weight (Z-score, female) - increased
Body Weight (Z-score, male) - decreased
Body Weight (Z-score, male) - increased
Bone: Femur Length (AI, residual) - decreased
Bone: Femur Length (AI, residual) - increased
Bone: Femur Length (AI, residual, female) - decreased
Bone: Femur Length (AI, residual, female) - increased
Bone: Femur Length (AI, residual, male) - decreased
Bone: Femur Length (AI, residual, male) - increased
Bone: Fore Hip Distance (AI) - decreased
Bone: Fore Hip Distance (AI) - increased
Bone: Fore Hip Distance (AI, female) - decreased
Bone: Fore Hip Distance (AI, female) - increased
Bone: Fore Hip Distance (AI, male) - decreased
Bone: Fore Hip Distance (AI, male) - increased
Bone: Hind Hip Distance (AI) - decreased
Bone: Hind Hip Distance (AI) - increased
Bone: Hind Hip Distance (AI, female) - decreased
Bone: Hind Hip Distance (AI, female) - increased
Bone: Hind Hip Distance (AI, male) - decreased
Bone: Hind Hip Distance (AI, male) - increased
Bone: Hip Ratio (AI) - decreased
Bone: Hip Ratio (AI) - increased
Bone: Pelvis Length (AI, residual) - decreased
Bone: Pelvis Length (AI, residual) - increased
Bone: Pelvis Length (AI, residual, female) - decreased
Bone: Pelvis Length (AI, residual, female) - increased
Bone: Pelvis Length (AI, residual, male) - decreased
Bone: Pelvis Length (AI, residual, male) - increased
Bone: Spine Deformity (female)
Bone: Spine Deformity (male)
Bone: Tibia Length (AI, residual) - decreased
Bone: Tibia Length (AI, residual) - increased
Bone: Tibia Length (AI, residual, female) - decreased
Bone: Tibia Length (AI, residual, female) - increased
Bone: Tibia Length (AI, residual, male) - decreased
Bone: Tibia Length (AI, residual, male) - increased
cardiovascular system
CD8 response - decreased
cellular phenotype
craniofacial
CTL killing - decreased
CTL killing - increased
CTL killing dominant epitope - decreased
CTL killing dominant epitope - increased
CTL killing subdominant epitope - decreased
CTL killing subdominant epitope - increased
digestive/alimentary
dsDNA Antibody - decreased
dsDNA Antibody - increased
dsDNA induced type I IFN production - decreased
dsDNA induced type I IFN production - increased
DSS: resistant
DSS: resistant day 10
DSS: resistant day 7
DSS: sensitive day 10
DSS: sensitive day 7
embryogenesis
endocrine/exocrine gland
extracellular cGAMP: high response
extracellular cGAMP: low response
eye: micro-ophthalmia
Eye: SL-OCT BM to ILM thickness - decreased
Eye: SL-OCT BM to ILM thickness - increased
Eye: SL-OCT BM to ILM thickness (base) - decreased
Eye: SL-OCT BM to ILM thickness (base) - increased
Eye: SL-OCT BM to ILM thickness (delta) - decreased
Eye: SL-OCT BM to ILM thickness (delta) - increased
Eye: SL-OCT INL to ILM thickness - decreased
Eye: SL-OCT INL to ILM thickness - increased
Eye: SL-OCT INL to ILM thickness (base) - decreased
Eye: SL-OCT INL to ILM thickness (base) - increased
Eye: SL-OCT INL to ILM thickness (delta) - decreased
Eye: SL-OCT INL to ILM thickness (delta) - increased
Eye: SL-OCT IPL to ILM thickness - decreased
Eye: SL-OCT IPL to ILM thickness - increased
Eye: SL-OCT IPL to ILM thickness (base) - decreased
Eye: SL-OCT IPL to ILM thickness (base) - increased
Eye: SL-OCT IPL to ILM thickness (delta) - decreased
Eye: SL-OCT IPL to ILM thickness (delta) - increased
FACS B cells - decreased
FACS B cells - increased
FACS B:T cells - decreased
FACS B:T cells - increased
FACS B1 cells - decreased
FACS B1 cells - increased
FACS B1a cells - decreased
FACS B1a cells - increased
FACS B1a cells in B1 cells - decreased
FACS B1a cells in B1 cells - increased
FACS B1b cells - decreased
FACS B1b cells - increased
FACS B1b cells in B1 cells - decreased
FACS B1b cells in B1 cells - increased
FACS B2 cells - decreased
FACS B2 cells - increased
FACS B220 MFI - decreased
FACS B220 MFI - increased
FACS CD11b+ DCs (gated in CD11c+ cells) - decreased
FACS CD11b+ DCs (gated in CD11c+ cells) - increased
FACS CD11c+ DCs - decreased
FACS CD11c+ DCs - increased
FACS CD4:CD8 - decreased
FACS CD4:CD8 - increased
FACS CD4+ T cells - decreased
FACS CD4+ T cells - increased
FACS CD4+ T cells in CD3+ T cells - decreased
FACS CD4+ T cells in CD3+ T cells - increased
FACS CD44+ CD4 MFI - decreased
FACS CD44+ CD4 MFI - increased
FACS CD44+ CD4 T cells - decreased
FACS CD44+ CD4 T cells - increased
FACS CD44+ CD8 MFI - decreased
FACS CD44+ CD8 MFI - increased
FACS CD44+ CD8 T cells - decreased
FACS CD44+ CD8 T cells - increased
FACS CD44+ T cells - decreased
FACS CD44+ T cells - increased
FACS CD44+ T MFI - decreased
FACS CD44+ T MFI - increased
FACS CD8+ T cells - decreased
FACS CD8+ T cells - increased
FACS CD8+ T cells in CD3+ T cells - decreased
FACS CD8+ T cells in CD3+ T cells - increased
FACS CD8a+ DCs (gated in CD11c+ cells) - decreased
FACS CD8a+ DCs (gated in CD11c+ cells) - increased
FACS central memory CD4 T cells in CD4 T cells - decreased
FACS central memory CD4 T cells in CD4 T cells - increased
FACS central memory CD8 T cells in CD8 T cells - decreased
FACS central memory CD8 T cells in CD8 T cells - increased
FACS effector memory CD4 T cells in CD4 T cells - decreased
FACS effector memory CD4 T cells in CD4 T cells - increased
FACS effector memory CD8 T cells in CD8 T cells - decreased
FACS effector memory CD8 T cells in CD8 T cells - increased
FACS effector T cells - decreased
FACS effector T cells - increased
FACS IgD MFI - decreased
FACS IgD MFI - increased
FACS IgD+ B cell percentage - decreased
FACS IgD+ B cell percentage - increased
FACS IgM MFI - decreased
FACS IgM MFI - increased
FACS IgM+ B cells - decreased
FACS IgM+ B cells - increased
FACS macrophages - decreased
FACS macrophages - increased
FACS memory T cells - decreased
FACS memory T cells - increased
FACS naive CD4 T cells in CD4 T cells - decreased
FACS naive CD4 T cells in CD4 T cells - increased
FACS naive CD8 T cells in CD8 T cells - decreased
FACS naive CD8 T cells in CD8 T cells - increased
FACS naive T cells - decreased
FACS naive T cells - increased
FACS neutrophils - decreased
FACS neutrophils - increased
FACS NK cells - decreased
FACS NK cells - increased
FACS NK1.1+ T cells - decreased
FACS NK1.1+ T cells - increased
FACS NKT cells (tet) - decreased
FACS NKT cells (tet) - increased
FACS pDCs - decreased
FACS pDCs - increased
FACS T cells - decreased
FACS T cells - increased
growth/size
hearing/vestibular/ear
hematopoietic competition - disadvantage
hematopoietic system
homeostasis/metabolism
IgA response to 2nd OVA/Alum Challenge (day 7) - decreased
IgA response to 2nd OVA/Alum Challenge (day 7) - increased
IgE response to a Cysteine Protease (Papain) - decreased
IgE response to a Cysteine Protease (Papain) - increased
IgG1 response to a Cysteine Protease (Papain) - decreased
IgG1 response to a Cysteine Protease (Papain) - increased
immune system
impaired response to dsDNA- type I IFN production by macrophages
inflammatory bowel disease phenotype
influenza proliferation in macrophages - decreased
influenza proliferation in macrophages - increased
influenza resistance
iron deficiency
iron excess
LCMV clone 13 resistance
lethality-embryonic/perinatal
lethality-postnatal
life span-post-weaning/aging
limbs/digits/tail phenotype
liver/biliary system
LPS Cachexia: Body Weight (day 0) - decreased
LPS Cachexia: Body Weight (day 0) - increased
LPS Cachexia: Body Weight (day 0, z-score) - decreased
LPS Cachexia: Body Weight (day 0, z-score) - increased
LPS Cachexia: Body Weight (day 1) - decreased
LPS Cachexia: Body Weight (day 1) - increased
LPS Cachexia: Body Weight (day 14) - decreased
LPS Cachexia: Body Weight (day 14) - increased
LPS Cachexia: Body Weight (day 2) - decreased
LPS Cachexia: Body Weight (day 2) - increased
LPS Cachexia: Body Weight Change (day 1, g) - decreased
LPS Cachexia: Body Weight Change (day 1, g) - increased
LPS Cachexia: Body Weight Change (day 1, ratio) - decreased
LPS Cachexia: Body Weight Change (day 1, ratio) - increased
LPS Cachexia: Body Weight Change (day 14, g) - decreased
LPS Cachexia: Body Weight Change (day 14, g) - increased
LPS Cachexia: Body Weight Change (day 14, ratio) - decreased
LPS Cachexia: Body Weight Change (day 14, ratio) - increased
LPS Cachexia: Body Weight Change (day 2, g) - decreased
LPS Cachexia: Body Weight Change (day 2, g) - increased
LPS Cachexia: Body Weight Change (day 2, ratio) - decreased
LPS Cachexia: Body Weight Change (day 2, ratio) - increased
LPS Hypersensitivity - decreased
LPS Hypersensitivity - increased
LPS-induced Necroptosis - decreased
LPS-induced Necroptosis - increased
Macrophage necroptosis: high
Macrophage necroptosis: low
MC38 tumor body weight change (%) - decreased
MC38 tumor body weight change (%) - increased
MC38 tumor body weight change (%, female) - decreased
MC38 tumor body weight change (%, female) - increased
MC38 tumor body weight change (%, male) - decreased
MC38 tumor body weight change (%, male) - increased
MC38 tumor body weight change (g) - decreased
MC38 tumor body weight change (g) - increased
MC38 tumor body weight change (g, female) - decreased
MC38 tumor body weight change (g, female) - increased
MC38 tumor body weight change (g, male) - decreased
MC38 tumor body weight change (g, male) - increased
MC38 tumor volume (day 22) - decreased
MC38 tumor volume (day 22) - increased
MC38 tumor volume (day 22, early sac sick or found dead, IM injection, dermatitis, trimmed) - decreased
MC38 tumor volume (day 22, early sac sick or found dead, IM injection, dermatitis, trimmed) - increased
MCMV proliferation in macrophages - decreased
MCMV proliferation in macrophages - increased
MCMV resistance
MCMV susceptibility
MTT dsDNA PECs - decreased
MTT dsDNA PECs - increased
MTT Value of PECs - decreased
MTT Value of PECs - increased
muscle
NALP3 inflammasome signaling defect
nervous system
NK cell response - decreased
NK killing - decreased
NK killing - increased
Nlrc4 inflammasome: high response
Nlrc4 inflammasome: low response
NLRP3 inflammasome: high response
NLRP3 inflammasome: low response
no phenotypic analysis
normal phenotype
other phenotype
OVA-specific IgE - decreased
OVA-specific IgE - increased
OVA-specific IgE after 2nd OVA/Alum - decreased
OVA-specific IgE after 2nd OVA/Alum - increased
Peritoneal exudates B1a cell % - decreased
Peritoneal exudates B1a cell % - increased
Peritoneal exudates B1a cell numbers - decreased
Peritoneal exudates B1a cell numbers - increased
Peritoneal exudates B1b cell % - decreased
Peritoneal exudates B1b cell % - increased
Peritoneal exudates B1b cell numbers - decreased
Peritoneal exudates B1b cell numbers - increased
Peritoneal exudates macrophage % - decreased
Peritoneal exudates macrophage % - increased
Peritoneal exudates macrophage numbers - decreased
Peritoneal exudates macrophage numbers - increased
Peritoneal exudates neutrophil % - decreased
Peritoneal exudates neutrophil % - increased
Peritoneal exudates neutrophil numbers - decreased
Peritoneal exudates neutrophil numbers - increased
phagocytosis in PECs - decreased
phagocytosis in PECs - increased
pigmentation
polycythemia
post-MCMV FACS B cells - decreased
post-MCMV FACS B cells - increased
post-MCMV FACS B:T cells - decreased
post-MCMV FACS B:T cells - increased
post-MCMV FACS B1 cells - decreased
post-MCMV FACS B1 cells - increased
post-MCMV FACS B1a cells - decreased
post-MCMV FACS B1a cells - increased
post-MCMV FACS B1a cells in B1 cells - decreased
post-MCMV FACS B1a cells in B1 cells - increased
post-MCMV FACS B1b cells - decreased
post-MCMV FACS B1b cells - increased
post-MCMV FACS B1b cells in B1 cells - decreased
post-MCMV FACS B1b cells in B1 cells - increased
post-MCMV FACS B2 cells - decreased
post-MCMV FACS B2 cells - increased
post-MCMV FACS B220 MFI - decreased
post-MCMV FACS B220 MFI - increased
post-MCMV FACS CD11b+ DCs (gated in CD11c+ cells) - decreased
post-MCMV FACS CD11b+ DCs (gated in CD11c+ cells) - increased
post-MCMV FACS CD11c+ DCs - decreased
post-MCMV FACS CD11c+ DCs - increased
post-MCMV FACS CD4:CD8 - decreased
post-MCMV FACS CD4:CD8 - increased
post-MCMV FACS CD4+ T cells - decreased
post-MCMV FACS CD4+ T cells - increased
post-MCMV FACS CD4+ T cells in CD3+ T cells - decreased
post-MCMV FACS CD4+ T cells in CD3+ T cells - increased
post-MCMV FACS CD44+ CD4 MFI - decreased
post-MCMV FACS CD44+ CD4 MFI - increased
post-MCMV FACS CD44+ CD4 T cells - decreased
post-MCMV FACS CD44+ CD4 T cells - increased
post-MCMV FACS CD44+ CD8 MFI - decreased
post-MCMV FACS CD44+ CD8 MFI - increased
post-MCMV FACS CD44+ CD8 T cells - decreased
post-MCMV FACS CD44+ CD8 T cells - increased
post-MCMV FACS CD44+ T cells - decreased
post-MCMV FACS CD44+ T cells - increased
post-MCMV FACS CD44+ T MFI - decreased
post-MCMV FACS CD44+ T MFI - increased
post-MCMV FACS CD8+ T cells - decreased
post-MCMV FACS CD8+ T cells - increased
post-MCMV FACS CD8+ T cells in CD3+ T cells - decreased
post-MCMV FACS CD8+ T cells in CD3+ T cells - increased
post-MCMV FACS CD8a+ DCs (gated in CD11c+ cells) - decreased
post-MCMV FACS CD8a+ DCs (gated in CD11c+ cells) - increased
post-MCMV FACS central memory CD4 T cells in CD4 T cells - decreased
post-MCMV FACS central memory CD4 T cells in CD4 T cells - increased
post-MCMV FACS central memory CD8 T cells in CD8 T cells - decreased
post-MCMV FACS central memory CD8 T cells in CD8 T cells - increased
post-MCMV FACS effector memory CD4 T cells in CD4 T cells - decreased
post-MCMV FACS effector memory CD4 T cells in CD4 T cells - increased
post-MCMV FACS effector memory CD8 T cells in CD8 T cells - decreased
post-MCMV FACS effector memory CD8 T cells in CD8 T cells - increased
post-MCMV FACS effector T cells - decreased
post-MCMV FACS effector T cells - increased
post-MCMV FACS IgD MFI - decreased
post-MCMV FACS IgD MFI - increased
post-MCMV FACS IgD+ B cell percentage - decreased
post-MCMV FACS IgD+ B cell percentage - increased
post-MCMV FACS IgM MFI - decreased
post-MCMV FACS IgM MFI - increased
post-MCMV FACS IgM+ B cells - decreased
post-MCMV FACS IgM+ B cells - increased
post-MCMV FACS macrophages - decreased
post-MCMV FACS macrophages - increased
post-MCMV FACS memory T cells - decreased
post-MCMV FACS memory T cells - increased
post-MCMV FACS naive CD4 T cells in CD4 T cells - decreased
post-MCMV FACS naive CD4 T cells in CD4 T cells - increased
post-MCMV FACS naive CD8 T cells in CD8 T cells - decreased
post-MCMV FACS naive CD8 T cells in CD8 T cells - increased
post-MCMV FACS naive T cells - decreased
post-MCMV FACS naive T cells - increased
post-MCMV FACS neutrophils - decreased
post-MCMV FACS neutrophils - increased
post-MCMV FACS NK cells - decreased
post-MCMV FACS NK cells - increased
post-MCMV FACS NK T cells - decreased
post-MCMV FACS NK T cells - increased
post-MCMV FACS NKT cells (tet) - decreased
post-MCMV FACS NKT cells (tet) - increased
post-MCMV FACS pDCs - decreased
post-MCMV FACS pDCs - increased
post-MCMV FACS T cells - decreased
post-MCMV FACS T cells - increased
ratio of OVA-specific IgE over the total IgE - decreased
ratio of OVA-specific IgE over the total IgE - increased
renal/urinary system
reproductive system
resistance to B10-F16 melanoma - decreased
resistance to B10-F16 melanoma - increased
respiratory system
response to injected CpG DNA - decreased
RVFV proliferation in macrophages - decreased
RVFV proliferation in macrophages - increased
RVFV susceptibility
secretory SlgA after 2nd OVA/Alum Challenge (day 7) - decreased
secretory SlgA after 2nd OVA/Alum Challenge (day 7) - increased
skeleton phenotype
skin/coat/nails
taste/olfaction
T-dependent humoral response defect- decreased antibody response to OVA+ alum immunization
T-dependent humoral response defect- decreased antibody response to rSFV
T-dependent humoral response defect- increased antibody response to OVA+ alum immunization
T-dependent humoral response defect- increased antibody response to rSFV
T-independent B cell response defect- decreased TNP-specific IgM to TNP-Ficoll immunization
T-independent B cell response defect- increased TNP-specific IgM to TNP-Ficoll immunization
TLR signaling defect: hypersensitivity to CpG + IFNg
TLR signaling defect: hypersensitivity to LPS
TLR signaling defect: hypersensitivity to MALP2
TLR signaling defect: hypersensitivity to PAM3CSK4
TLR signaling defect: hypersensitivity to poly I:C
TLR signaling defect: hypersensitivity to poly I:C + IFNg
TLR signaling defect: hypersensitivity to R848
TLR signaling defect: hyposensitivity to CpG + IFNg
TLR signaling defect: hyposensitivity to LPS
TLR signaling defect: hyposensitivity to MALP2
TLR signaling defect: hyposensitivity to PAM3CSK4
TLR signaling defect: hyposensitivity to poly I:C
TLR signaling defect: hyposensitivity to poly I:C + IFNg
TLR signaling defect: hyposensitivity to R848
TLR signaling defect: TNF production by macrophages
total IgE after 2nd OVA/Alum - decreased
total IgE after 2nd OVA/Alum - increased
Total IgE After 2nd OVA/Alum Challenge (day 7) - decreased
Total IgE After 2nd OVA/Alum Challenge (day 7) - increased
total IgE level - decreased
total IgE level - increased
touch/vibrissae
tumorigenesis
vision/eye
and
none of
any of
125-03 Response - decreased
125-03 Response - increased
30 min GTT hyperglycemic
30 min GTT hyperglycemic (male)
30 min GTT hyperoglycemic (female)
30 min GTT hypoglycemic
30 min GTT hypoglycemic (female)
30 min GTT hypoglycemic (male)
adenovirus infection of macrophages - decreased
adenovirus infection of macrophages - increased
adipose tissue
anemia
Anophthalmia
Aut: Interaction - decreased
Aut: Interaction - increased
autoimmunity
behavior/neurological
Blood Analysis EO% - decreased
Blood Analysis EO% - increased
Blood Analysis Hb - decreased
Blood Analysis Hb - increased
Blood Analysis HCT - decreased
Blood Analysis HCT - increased
Blood Analysis LY# - decreased
Blood Analysis LY# - increased
Blood Analysis MCH - decreased
Blood Analysis MCH - increased
Blood Analysis MCHC - decreased
Blood Analysis MCHC - increased
Blood Analysis MCV - decreased
Blood Analysis MCV - increased
Blood Analysis MO# - decreased
Blood Analysis MO# - increased
Blood Analysis NE# - decreased
Blood Analysis NE# - increased
Blood Analysis Platelet Count - decreased
Blood Analysis Platelet Count - increased
Blood Analysis RBC - decreased
Blood Analysis RBC - increased
Blood Analysis RDW - decreased
Blood Analysis RDW - increased
Blood Analysis WBC - decreased
Blood Analysis WBC - increased
Blood Pressure: Pooled HR - decreased
Blood Pressure: Pooled HR - increased
Blood Pressure: Pooled SBP - decreased
Blood Pressure: Pooled SBP - increased
Body Weight - decreased
Body Weight - increased
Body Weight (BP, z-score, female) - decreased
Body Weight (BP, z-score, female) - increased
Body Weight (BP, z-score, male) - decreased
Body Weight (BP, z-score, male) - increased
Body Weight (DSS Female) - decreased
Body Weight (DSS Female) - increased
Body Weight (DSS Male) - decreased
Body Weight (DSS Male) - increased
Body Weight (DSS) - decreased
Body Weight (DSS) - increased
Body Weight (DSS, Day10) - decreased
Body Weight (DSS, Day10) - increased
Body Weight (DSS, Day7) - decreased
Body Weight (DSS, Day7) - increased
Body Weight (DSS, z-score) - decreased
Body Weight (DSS, z-score) - increased
Body Weight (DSS, z-score, female) - decreased
Body Weight (DSS, z-score, female) - increased
Body Weight (DSS, z-score, male) - decreased
Body Weight (DSS, z-score, male) - increased
Body Weight (Female) - decreased
Body Weight (Female) - increased
Body Weight (Male) - decreased
Body Weight (Male) - increased
Body Weight (Z-score) - decreased
Body Weight (Z-score) - increased
Body Weight (Z-score, female) - decreased
Body Weight (Z-score, female) - increased
Body Weight (Z-score, male) - decreased
Body Weight (Z-score, male) - increased
Bone: Femur Length (AI, residual) - decreased
Bone: Femur Length (AI, residual) - increased
Bone: Femur Length (AI, residual, female) - decreased
Bone: Femur Length (AI, residual, female) - increased
Bone: Femur Length (AI, residual, male) - decreased
Bone: Femur Length (AI, residual, male) - increased
Bone: Fore Hip Distance (AI) - decreased
Bone: Fore Hip Distance (AI) - increased
Bone: Fore Hip Distance (AI, female) - decreased
Bone: Fore Hip Distance (AI, female) - increased
Bone: Fore Hip Distance (AI, male) - decreased
Bone: Fore Hip Distance (AI, male) - increased
Bone: Hind Hip Distance (AI) - decreased
Bone: Hind Hip Distance (AI) - increased
Bone: Hind Hip Distance (AI, female) - decreased
Bone: Hind Hip Distance (AI, female) - increased
Bone: Hind Hip Distance (AI, male) - decreased
Bone: Hind Hip Distance (AI, male) - increased
Bone: Hip Ratio (AI) - decreased
Bone: Hip Ratio (AI) - increased
Bone: Pelvis Length (AI, residual) - decreased
Bone: Pelvis Length (AI, residual) - increased
Bone: Pelvis Length (AI, residual, female) - decreased
Bone: Pelvis Length (AI, residual, female) - increased
Bone: Pelvis Length (AI, residual, male) - decreased
Bone: Pelvis Length (AI, residual, male) - increased
Bone: Spine Deformity (female)
Bone: Spine Deformity (male)
Bone: Tibia Length (AI, residual) - decreased
Bone: Tibia Length (AI, residual) - increased
Bone: Tibia Length (AI, residual, female) - decreased
Bone: Tibia Length (AI, residual, female) - increased
Bone: Tibia Length (AI, residual, male) - decreased
Bone: Tibia Length (AI, residual, male) - increased
cardiovascular system
CD8 response - decreased
cellular phenotype
craniofacial
CTL killing - decreased
CTL killing - increased
CTL killing dominant epitope - decreased
CTL killing dominant epitope - increased
CTL killing subdominant epitope - decreased
CTL killing subdominant epitope - increased
digestive/alimentary
dsDNA Antibody - decreased
dsDNA Antibody - increased
dsDNA induced type I IFN production - decreased
dsDNA induced type I IFN production - increased
DSS: resistant
DSS: resistant day 10
DSS: resistant day 7
DSS: sensitive day 10
DSS: sensitive day 7
embryogenesis
endocrine/exocrine gland
extracellular cGAMP: high response
extracellular cGAMP: low response
eye: micro-ophthalmia
Eye: SL-OCT BM to ILM thickness - decreased
Eye: SL-OCT BM to ILM thickness - increased
Eye: SL-OCT BM to ILM thickness (base) - decreased
Eye: SL-OCT BM to ILM thickness (base) - increased
Eye: SL-OCT BM to ILM thickness (delta) - decreased
Eye: SL-OCT BM to ILM thickness (delta) - increased
Eye: SL-OCT INL to ILM thickness - decreased
Eye: SL-OCT INL to ILM thickness - increased
Eye: SL-OCT INL to ILM thickness (base) - decreased
Eye: SL-OCT INL to ILM thickness (base) - increased
Eye: SL-OCT INL to ILM thickness (delta) - decreased
Eye: SL-OCT INL to ILM thickness (delta) - increased
Eye: SL-OCT IPL to ILM thickness - decreased
Eye: SL-OCT IPL to ILM thickness - increased
Eye: SL-OCT IPL to ILM thickness (base) - decreased
Eye: SL-OCT IPL to ILM thickness (base) - increased
Eye: SL-OCT IPL to ILM thickness (delta) - decreased
Eye: SL-OCT IPL to ILM thickness (delta) - increased
FACS B cells - decreased
FACS B cells - increased
FACS B:T cells - decreased
FACS B:T cells - increased
FACS B1 cells - decreased
FACS B1 cells - increased
FACS B1a cells - decreased
FACS B1a cells - increased
FACS B1a cells in B1 cells - decreased
FACS B1a cells in B1 cells - increased
FACS B1b cells - decreased
FACS B1b cells - increased
FACS B1b cells in B1 cells - decreased
FACS B1b cells in B1 cells - increased
FACS B2 cells - decreased
FACS B2 cells - increased
FACS B220 MFI - decreased
FACS B220 MFI - increased
FACS CD11b+ DCs (gated in CD11c+ cells) - decreased
FACS CD11b+ DCs (gated in CD11c+ cells) - increased
FACS CD11c+ DCs - decreased
FACS CD11c+ DCs - increased
FACS CD4:CD8 - decreased
FACS CD4:CD8 - increased
FACS CD4+ T cells - decreased
FACS CD4+ T cells - increased
FACS CD4+ T cells in CD3+ T cells - decreased
FACS CD4+ T cells in CD3+ T cells - increased
FACS CD44+ CD4 MFI - decreased
FACS CD44+ CD4 MFI - increased
FACS CD44+ CD4 T cells - decreased
FACS CD44+ CD4 T cells - increased
FACS CD44+ CD8 MFI - decreased
FACS CD44+ CD8 MFI - increased
FACS CD44+ CD8 T cells - decreased
FACS CD44+ CD8 T cells - increased
FACS CD44+ T cells - decreased
FACS CD44+ T cells - increased
FACS CD44+ T MFI - decreased
FACS CD44+ T MFI - increased
FACS CD8+ T cells - decreased
FACS CD8+ T cells - increased
FACS CD8+ T cells in CD3+ T cells - decreased
FACS CD8+ T cells in CD3+ T cells - increased
FACS CD8a+ DCs (gated in CD11c+ cells) - decreased
FACS CD8a+ DCs (gated in CD11c+ cells) - increased
FACS central memory CD4 T cells in CD4 T cells - decreased
FACS central memory CD4 T cells in CD4 T cells - increased
FACS central memory CD8 T cells in CD8 T cells - decreased
FACS central memory CD8 T cells in CD8 T cells - increased
FACS effector memory CD4 T cells in CD4 T cells - decreased
FACS effector memory CD4 T cells in CD4 T cells - increased
FACS effector memory CD8 T cells in CD8 T cells - decreased
FACS effector memory CD8 T cells in CD8 T cells - increased
FACS effector T cells - decreased
FACS effector T cells - increased
FACS IgD MFI - decreased
FACS IgD MFI - increased
FACS IgD+ B cell percentage - decreased
FACS IgD+ B cell percentage - increased
FACS IgM MFI - decreased
FACS IgM MFI - increased
FACS IgM+ B cells - decreased
FACS IgM+ B cells - increased
FACS macrophages - decreased
FACS macrophages - increased
FACS memory T cells - decreased
FACS memory T cells - increased
FACS naive CD4 T cells in CD4 T cells - decreased
FACS naive CD4 T cells in CD4 T cells - increased
FACS naive CD8 T cells in CD8 T cells - decreased
FACS naive CD8 T cells in CD8 T cells - increased
FACS naive T cells - decreased
FACS naive T cells - increased
FACS neutrophils - decreased
FACS neutrophils - increased
FACS NK cells - decreased
FACS NK cells - increased
FACS NK1.1+ T cells - decreased
FACS NK1.1+ T cells - increased
FACS NKT cells (tet) - decreased
FACS NKT cells (tet) - increased
FACS pDCs - decreased
FACS pDCs - increased
FACS T cells - decreased
FACS T cells - increased
growth/size
hearing/vestibular/ear
hematopoietic competition - disadvantage
hematopoietic system
homeostasis/metabolism
IgA response to 2nd OVA/Alum Challenge (day 7) - decreased
IgA response to 2nd OVA/Alum Challenge (day 7) - increased
IgE response to a Cysteine Protease (Papain) - decreased
IgE response to a Cysteine Protease (Papain) - increased
IgG1 response to a Cysteine Protease (Papain) - decreased
IgG1 response to a Cysteine Protease (Papain) - increased
immune system
impaired response to dsDNA- type I IFN production by macrophages
inflammatory bowel disease phenotype
influenza proliferation in macrophages - decreased
influenza proliferation in macrophages - increased
influenza resistance
iron deficiency
iron excess
LCMV clone 13 resistance
lethality-embryonic/perinatal
lethality-postnatal
life span-post-weaning/aging
limbs/digits/tail phenotype
liver/biliary system
LPS Cachexia: Body Weight (day 0) - decreased
LPS Cachexia: Body Weight (day 0) - increased
LPS Cachexia: Body Weight (day 0, z-score) - decreased
LPS Cachexia: Body Weight (day 0, z-score) - increased
LPS Cachexia: Body Weight (day 1) - decreased
LPS Cachexia: Body Weight (day 1) - increased
LPS Cachexia: Body Weight (day 14) - decreased
LPS Cachexia: Body Weight (day 14) - increased
LPS Cachexia: Body Weight (day 2) - decreased
LPS Cachexia: Body Weight (day 2) - increased
LPS Cachexia: Body Weight Change (day 1, g) - decreased
LPS Cachexia: Body Weight Change (day 1, g) - increased
LPS Cachexia: Body Weight Change (day 1, ratio) - decreased
LPS Cachexia: Body Weight Change (day 1, ratio) - increased
LPS Cachexia: Body Weight Change (day 14, g) - decreased
LPS Cachexia: Body Weight Change (day 14, g) - increased
LPS Cachexia: Body Weight Change (day 14, ratio) - decreased
LPS Cachexia: Body Weight Change (day 14, ratio) - increased
LPS Cachexia: Body Weight Change (day 2, g) - decreased
LPS Cachexia: Body Weight Change (day 2, g) - increased
LPS Cachexia: Body Weight Change (day 2, ratio) - decreased
LPS Cachexia: Body Weight Change (day 2, ratio) - increased
LPS Hypersensitivity - decreased
LPS Hypersensitivity - increased
LPS-induced Necroptosis - decreased
LPS-induced Necroptosis - increased
Macrophage necroptosis: high
Macrophage necroptosis: low
MC38 tumor body weight change (%) - decreased
MC38 tumor body weight change (%) - increased
MC38 tumor body weight change (%, female) - decreased
MC38 tumor body weight change (%, female) - increased
MC38 tumor body weight change (%, male) - decreased
MC38 tumor body weight change (%, male) - increased
MC38 tumor body weight change (g) - decreased
MC38 tumor body weight change (g) - increased
MC38 tumor body weight change (g, female) - decreased
MC38 tumor body weight change (g, female) - increased
MC38 tumor body weight change (g, male) - decreased
MC38 tumor body weight change (g, male) - increased
MC38 tumor volume (day 22) - decreased
MC38 tumor volume (day 22) - increased
MC38 tumor volume (day 22, early sac sick or found dead, IM injection, dermatitis, trimmed) - decreased
MC38 tumor volume (day 22, early sac sick or found dead, IM injection, dermatitis, trimmed) - increased
MCMV proliferation in macrophages - decreased
MCMV proliferation in macrophages - increased
MCMV resistance
MCMV susceptibility
MTT dsDNA PECs - decreased
MTT dsDNA PECs - increased
MTT Value of PECs - decreased
MTT Value of PECs - increased
muscle
NALP3 inflammasome signaling defect
nervous system
NK cell response - decreased
NK killing - decreased
NK killing - increased
Nlrc4 inflammasome: high response
Nlrc4 inflammasome: low response
NLRP3 inflammasome: high response
NLRP3 inflammasome: low response
no phenotypic analysis
normal phenotype
other phenotype
OVA-specific IgE - decreased
OVA-specific IgE - increased
OVA-specific IgE after 2nd OVA/Alum - decreased
OVA-specific IgE after 2nd OVA/Alum - increased
Peritoneal exudates B1a cell % - decreased
Peritoneal exudates B1a cell % - increased
Peritoneal exudates B1a cell numbers - decreased
Peritoneal exudates B1a cell numbers - increased
Peritoneal exudates B1b cell % - decreased
Peritoneal exudates B1b cell % - increased
Peritoneal exudates B1b cell numbers - decreased
Peritoneal exudates B1b cell numbers - increased
Peritoneal exudates macrophage % - decreased
Peritoneal exudates macrophage % - increased
Peritoneal exudates macrophage numbers - decreased
Peritoneal exudates macrophage numbers - increased
Peritoneal exudates neutrophil % - decreased
Peritoneal exudates neutrophil % - increased
Peritoneal exudates neutrophil numbers - decreased
Peritoneal exudates neutrophil numbers - increased
phagocytosis in PECs - decreased
phagocytosis in PECs - increased
pigmentation
polycythemia
post-MCMV FACS B cells - decreased
post-MCMV FACS B cells - increased
post-MCMV FACS B:T cells - decreased
post-MCMV FACS B:T cells - increased
post-MCMV FACS B1 cells - decreased
post-MCMV FACS B1 cells - increased
post-MCMV FACS B1a cells - decreased
post-MCMV FACS B1a cells - increased
post-MCMV FACS B1a cells in B1 cells - decreased
post-MCMV FACS B1a cells in B1 cells - increased
post-MCMV FACS B1b cells - decreased
post-MCMV FACS B1b cells - increased
post-MCMV FACS B1b cells in B1 cells - decreased
post-MCMV FACS B1b cells in B1 cells - increased
post-MCMV FACS B2 cells - decreased
post-MCMV FACS B2 cells - increased
post-MCMV FACS B220 MFI - decreased
post-MCMV FACS B220 MFI - increased
post-MCMV FACS CD11b+ DCs (gated in CD11c+ cells) - decreased
post-MCMV FACS CD11b+ DCs (gated in CD11c+ cells) - increased
post-MCMV FACS CD11c+ DCs - decreased
post-MCMV FACS CD11c+ DCs - increased
post-MCMV FACS CD4:CD8 - decreased
post-MCMV FACS CD4:CD8 - increased
post-MCMV FACS CD4+ T cells - decreased
post-MCMV FACS CD4+ T cells - increased
post-MCMV FACS CD4+ T cells in CD3+ T cells - decreased
post-MCMV FACS CD4+ T cells in CD3+ T cells - increased
post-MCMV FACS CD44+ CD4 MFI - decreased
post-MCMV FACS CD44+ CD4 MFI - increased
post-MCMV FACS CD44+ CD4 T cells - decreased
post-MCMV FACS CD44+ CD4 T cells - increased
post-MCMV FACS CD44+ CD8 MFI - decreased
post-MCMV FACS CD44+ CD8 MFI - increased
post-MCMV FACS CD44+ CD8 T cells - decreased
post-MCMV FACS CD44+ CD8 T cells - increased
post-MCMV FACS CD44+ T cells - decreased
post-MCMV FACS CD44+ T cells - increased
post-MCMV FACS CD44+ T MFI - decreased
post-MCMV FACS CD44+ T MFI - increased
post-MCMV FACS CD8+ T cells - decreased
post-MCMV FACS CD8+ T cells - increased
post-MCMV FACS CD8+ T cells in CD3+ T cells - decreased
post-MCMV FACS CD8+ T cells in CD3+ T cells - increased
post-MCMV FACS CD8a+ DCs (gated in CD11c+ cells) - decreased
post-MCMV FACS CD8a+ DCs (gated in CD11c+ cells) - increased
post-MCMV FACS central memory CD4 T cells in CD4 T cells - decreased
post-MCMV FACS central memory CD4 T cells in CD4 T cells - increased
post-MCMV FACS central memory CD8 T cells in CD8 T cells - decreased
post-MCMV FACS central memory CD8 T cells in CD8 T cells - increased
post-MCMV FACS effector memory CD4 T cells in CD4 T cells - decreased
post-MCMV FACS effector memory CD4 T cells in CD4 T cells - increased
post-MCMV FACS effector memory CD8 T cells in CD8 T cells - decreased
post-MCMV FACS effector memory CD8 T cells in CD8 T cells - increased
post-MCMV FACS effector T cells - decreased
post-MCMV FACS effector T cells - increased
post-MCMV FACS IgD MFI - decreased
post-MCMV FACS IgD MFI - increased
post-MCMV FACS IgD+ B cell percentage - decreased
post-MCMV FACS IgD+ B cell percentage - increased
post-MCMV FACS IgM MFI - decreased
post-MCMV FACS IgM MFI - increased
post-MCMV FACS IgM+ B cells - decreased
post-MCMV FACS IgM+ B cells - increased
post-MCMV FACS macrophages - decreased
post-MCMV FACS macrophages - increased
post-MCMV FACS memory T cells - decreased
post-MCMV FACS memory T cells - increased
post-MCMV FACS naive CD4 T cells in CD4 T cells - decreased
post-MCMV FACS naive CD4 T cells in CD4 T cells - increased
post-MCMV FACS naive CD8 T cells in CD8 T cells - decreased
post-MCMV FACS naive CD8 T cells in CD8 T cells - increased
post-MCMV FACS naive T cells - decreased
post-MCMV FACS naive T cells - increased
post-MCMV FACS neutrophils - decreased
post-MCMV FACS neutrophils - increased
post-MCMV FACS NK cells - decreased
post-MCMV FACS NK cells - increased
post-MCMV FACS NK T cells - decreased
post-MCMV FACS NK T cells - increased
post-MCMV FACS NKT cells (tet) - decreased
post-MCMV FACS NKT cells (tet) - increased
post-MCMV FACS pDCs - decreased
post-MCMV FACS pDCs - increased
post-MCMV FACS T cells - decreased
post-MCMV FACS T cells - increased
ratio of OVA-specific IgE over the total IgE - decreased
ratio of OVA-specific IgE over the total IgE - increased
renal/urinary system
reproductive system
resistance to B10-F16 melanoma - decreased
resistance to B10-F16 melanoma - increased
respiratory system
response to injected CpG DNA - decreased
RVFV proliferation in macrophages - decreased
RVFV proliferation in macrophages - increased
RVFV susceptibility
secretory SlgA after 2nd OVA/Alum Challenge (day 7) - decreased
secretory SlgA after 2nd OVA/Alum Challenge (day 7) - increased
skeleton phenotype
skin/coat/nails
taste/olfaction
T-dependent humoral response defect- decreased antibody response to OVA+ alum immunization
T-dependent humoral response defect- decreased antibody response to rSFV
T-dependent humoral response defect- increased antibody response to OVA+ alum immunization
T-dependent humoral response defect- increased antibody response to rSFV
T-independent B cell response defect- decreased TNP-specific IgM to TNP-Ficoll immunization
T-independent B cell response defect- increased TNP-specific IgM to TNP-Ficoll immunization
TLR signaling defect: hypersensitivity to CpG + IFNg
TLR signaling defect: hypersensitivity to LPS
TLR signaling defect: hypersensitivity to MALP2
TLR signaling defect: hypersensitivity to PAM3CSK4
TLR signaling defect: hypersensitivity to poly I:C
TLR signaling defect: hypersensitivity to poly I:C + IFNg
TLR signaling defect: hypersensitivity to R848
TLR signaling defect: hyposensitivity to CpG + IFNg
TLR signaling defect: hyposensitivity to LPS
TLR signaling defect: hyposensitivity to MALP2
TLR signaling defect: hyposensitivity to PAM3CSK4
TLR signaling defect: hyposensitivity to poly I:C
TLR signaling defect: hyposensitivity to poly I:C + IFNg
TLR signaling defect: hyposensitivity to R848
TLR signaling defect: TNF production by macrophages
total IgE after 2nd OVA/Alum - decreased
total IgE after 2nd OVA/Alum - increased
Total IgE After 2nd OVA/Alum Challenge (day 7) - decreased
Total IgE After 2nd OVA/Alum Challenge (day 7) - increased
total IgE level - decreased
total IgE level - increased
touch/vibrissae
tumorigenesis
vision/eye
and
validated
validated (with ENU)
validated (without ENU)
excluded
untested (pending)
untested (not pending)
validated
validated (with ENU)
validated (without ENU)
excluded
untested
Base Change
A
C
G
T
⇒
A
C
G
T
Type of Mutation
makesense
missense
nonsense
start codon destroyed
start gained
synonymous
splice acceptor site
splice donor site
critical splice acceptor site
critical splice donor site
splice site
large deletion
large insertion
rearrangement
small deletion
small insertion
exon
frame shift
intragenic
intron
utr 3 prime
utr 5 prime
unclassified
Exon Dist
Predicted Effect
unknown
probably benign
probably null
possibly damaging
probably damaging
noncoding transcript
silent
not run
no transcript
PPH Score
1
Chsy1
0.000
Chrysanthemum
7
66109515-66173798 bp (+)
66110229
Autosomal Dominant (2;10)
Autosomal Recessive (1;4), Autosomal Semidominant (3;16)
0.665
2022-04-02
Stephen Lyon
Body Weight - decreased
Body Weight (Female) - decreased
Body Weight (Male) - decreased
Body Weight (Z-score) - decreased
Body Weight (Z-score, female) - decreased
Body Weight (Z-score, male) - decreased
Bone: Femur Length (AI, residual) - decreased
Bone: Femur Length (AI, residual, female) - decreased
Bone: Femur Length (AI, residual, male) - decreased
FACS B1 cells - increased
T ⇒ G
critical splice donor site
2 bp
probably null
2
Acan
1.000
Vacuo
7
79053483-79115099 bp (+)
79088307
Autosomal Dominant (39;418)
0.827
2022-04-02
Stephen Lyon
Body Weight - decreased
Body Weight (BP, z-score, female) - decreased
Body Weight (Female) - decreased
Body Weight (Z-score) - decreased
Body Weight (Z-score, female) - decreased
Bone: Femur Length (AI, residual) - decreased
Bone: Femur Length (AI, residual, female) - decreased
Bone: Femur Length (AI, residual, male) - decreased
Bone: Fore Hip Distance (AI) - decreased
Bone: Fore Hip Distance (AI, female) - decreased
Bone: Pelvis Length (AI, residual) - decreased
Bone: Pelvis Length (AI, residual, female) - decreased
Bone: Pelvis Length (AI, residual, male) - decreased
Bone: Tibia Length (AI, residual) - decreased
Bone: Tibia Length (AI, residual, female) - decreased
Bone: Tibia Length (AI, residual, male) - decreased
LPS Cachexia: Body Weight (day 0) - decreased
LPS Cachexia: Body Weight (day 0, z-score) - decreased
LPS Cachexia: Body Weight (day 1) - decreased
LPS Cachexia: Body Weight (day 14) - decreased
LPS Cachexia: Body Weight (day 2) - decreased
T ⇒ G
critical splice donor site
2 bp
probably null
3
Tap1
0.000
rose2
17
34187553-34197225 bp (+)
34194941
Autosomal Dominant (2;9)
Autosomal Recessive (6;35), Autosomal Semidominant (1;6)
0.960
2019-09-04
Diantha La Vine
FACS CD4:CD8 - increased
MCMV susceptibility
post-MCMV FACS CD4:CD8 - increased
post-MCMV FACS CD4+ T cells - decreased
post-MCMV FACS CD44+ CD8 T cells - decreased
post-MCMV FACS CD44+ T cells - decreased
post-MCMV FACS CD8+ T cells - decreased
post-MCMV FACS IgM+ B cells - decreased
post-MCMV FACS T cells - decreased
T ⇒ G
missense
probably damaging
1.000
4
Atp7b
0.573
daffodil
8
21992785-22060305 bp (-)
21998266
Unknown (1;0)
failed initial filter
2019-09-04
Anne Murray
liver/biliary system
MTT Value of PECs - decreased
T ⇒ G
missense
probably damaging
1.000
5
Fasl
0.362
riogrande2
1
161780689-161788495 bp (-)
161787138
Autosomal Recessive (1;6)
0.092
2019-09-04
Anne Murray
T-dependent humoral response defect- decreased antibody response to rSFV
T ⇒ G
missense
probably benign
0.001
6
Rac2
0.000
Big_bend
15
78559167-78572783 bp (-)
78565945
Autosomal Dominant (2;3)
Autosomal Recessive (9;19), Autosomal Semidominant (2;10)
0.805
2019-09-04
Diantha La Vine
FACS B:T cells - increased
FACS B1 cells - decreased
FACS B1a cells - decreased
FACS B1a cells in B1 cells - decreased
FACS B1b cells - increased
FACS B1b cells in B1 cells - increased
FACS CD4:CD8 - increased
FACS CD8+ T cells - decreased
T-independent B cell response defect- decreased TNP-specific IgM to TNP-Ficoll immunization
TLR signaling defect: hypersensitivity to LPS
TLR signaling defect: hypersensitivity to PAM3CSK4
TLR signaling defect: hypersensitivity to R848
TLR signaling defect: TNF production by macrophages
T ⇒ G
missense
possibly damaging
0.955
7
Psap
1.000
twerk
10
60277627-60302597 bp (+)
60300851
Autosomal Dominant (1;1)
Autosomal Recessive (1;3)
failed initial filter
2019-09-04
Anne Murray
behavior/neurological
T ⇒ G
missense
probably damaging
1.000
8
Dock2
0.000
capitol_reef
11
34226815-34783892 bp (-)
34294170
Autosomal Recessive (8;53)
0.961
2019-09-04
Diantha La Vine
FACS CD4+ T cells in CD3+ T cells - decreased
FACS CD8+ T cells in CD3+ T cells - increased
OVA-specific IgE - increased
resistance to B10-F16 melanoma - decreased
total IgE level - increased
T ⇒ G
critical splice acceptor site
probably null
9
Dock2
0.000
Wharf
11
34226815-34783892 bp (-)
34732371
Autosomal Dominant (1;3)
0.538
2019-09-04
Diantha La Vine
FACS NK cells - increased
T ⇒ G
missense
possibly damaging
0.813
10
Ikbkb
1.000
Baby
8
22659212-22706589 bp (-)
22675036
Autosomal Dominant (1;7)
0.093
2019-09-04
Anne Murray
FACS central memory CD4 T cells in CD4 T cells - decreased
MCMV susceptibility
post-MCMV FACS B1a cells in B1 cells - decreased
post-MCMV FACS B1b cells in B1 cells - increased
post-MCMV FACS CD44+ CD4 MFI - decreased
post-MCMV FACS CD44+ CD8 MFI - decreased
post-MCMV FACS CD44+ CD8 T cells - decreased
post-MCMV FACS CD44+ T MFI - decreased
post-MCMV FACS CD8a+ DCs (gated in CD11c+ cells) - increased
post-MCMV FACS effector memory CD4 T cells in CD4 T cells - decreased
post-MCMV FACS effector memory CD8 T cells in CD8 T cells - decreased
TLR signaling defect: hyposensitivity to MALP2
T ⇒ G
missense
probably damaging
0.998
11
Dock2
0.000
Harborside
11
34226815-34783892 bp (-)
34262445
Autosomal Semidominant (2;9)
0.272
2019-09-04
Anne Murray
FACS CD8+ T cells - increased
FACS CD8+ T cells in CD3+ T cells - increased
T ⇒ G
missense
probably benign
0.000
12
Nlrp3
0.082
Park6
11
59541568-59566956 bp (+)
59549036
Autosomal Dominant (2;15)
0.875
2019-01-29
Diantha La Vine
NALP3 inflammasome signaling defect
NLRP3 inflammasome: low response
T ⇒ G
missense
probably damaging
0.999
13
Nlrp3
0.082
nd1
11
59541568-59566956 bp (+)
59565974
Unknown (1;0)
no linkage results
2019-01-29
Diantha La Vine
immune system
NALP3 inflammasome signaling defect
T ⇒ G
missense
probably benign
0.450
14
Lyst
0.288
charlotte_gray
13
13590397-13778803 bp (+)
13602026
Unknown
no linkage results
2018-08-02
Diantha La Vine
pigmentation
skin/coat/nails
T ⇒ G
intron
probably benign
15
Slc45a2
0.096
yuki
15
11000721-11029233 bp (+)
11001092
Unknown
no linkage results
2018-08-01
Diantha La Vine
pigmentation
skin/coat/nails
T ⇒ G
missense
probably damaging
1.000
16
Spink5
1.000
crusty2
18
43963235-44022501 bp (+)
43999935
Unknown (1;0)
no linkage results
2018-05-22
Anne Murray
immune system
lethality-postnatal
skin/coat/nails
T ⇒ G
splice site
6 bp
probably benign
17
Hr
0.000
prune
14
70552212-70573548 bp (+)
70571429
Unknown
no linkage results
2018-03-02
Diantha La Vine
Body Weight (DSS Male) - decreased
Body Weight (DSS, z-score, male) - decreased
DSS: sensitive day 10
DSS: sensitive day 7
FACS B cells - decreased
FACS B:T cells - decreased
FACS B1a cells - increased
FACS B1a cells in B1 cells - decreased
FACS B1b cells - increased
FACS B1b cells in B1 cells - increased
FACS B2 cells - decreased
FACS B220 MFI - increased
FACS CD4:CD8 - decreased
FACS CD4+ T cells - decreased
FACS CD4+ T cells in CD3+ T cells - decreased
FACS CD44+ CD8 MFI - increased
FACS CD44+ CD8 T cells - decreased
FACS CD44+ T cells - decreased
FACS CD8+ T cells - decreased
FACS CD8+ T cells in CD3+ T cells - increased
FACS central memory CD8 T cells in CD8 T cells - increased
FACS IgD+ B cell percentage - decreased
FACS IgM MFI - increased
FACS IgM+ B cells - decreased
FACS macrophages - increased
FACS naive CD8 T cells in CD8 T cells - decreased
FACS neutrophils - increased
FACS T cells - decreased
skin/coat/nails
T ⇒ G
missense
probably damaging
1.000
18
Traf3
1.000
bananasplit
12
111166370-111267153 bp (+)
111262036
Autosomal Recessive (2;18)
0.398
2017-10-14
Katherine Timer
FACS B2 cells - decreased
T-dependent humoral response defect- decreased antibody response to rSFV
T ⇒ G
missense
probably damaging
0.999
19
Rag2
0.000
snowcock
2
101624718-101632529 bp (+)
101630603
Autosomal Recessive (19;131)
Autosomal Semidominant (1;4)
0.855
2017-05-17
Anne Murray
FACS B cells - decreased
FACS B:T cells - decreased
FACS B1b cells - increased
FACS B2 cells - decreased
FACS B220 MFI - decreased
FACS CD11b+ DCs (gated in CD11c+ cells) - increased
FACS CD4+ T cells - decreased
FACS CD44+ CD4 MFI - increased
FACS CD44+ CD8 MFI - increased
FACS CD8+ T cells - decreased
FACS IgD MFI - decreased
FACS IgD+ B cell percentage - decreased
FACS IgM+ B cells - decreased
FACS macrophages - increased
FACS neutrophils - increased
FACS T cells - decreased
NALP3 inflammasome signaling defect
NLRP3 inflammasome: high response
T-dependent humoral response defect- decreased antibody response to OVA+ alum immunization
T-dependent humoral response defect- decreased antibody response to rSFV
T-independent B cell response defect- decreased TNP-specific IgM to TNP-Ficoll immunization
T ⇒ G
missense
probably damaging
0.999
20
Nfkbid
0.104
bumble
7
30421732-30428746 bp (+)
30425411
Unknown (2;0)
no linkage results
2017-03-28
Katherine Timer
FACS B cells - decreased
T-dependent humoral response defect- decreased antibody response to rSFV
T-independent B cell response defect- decreased TNP-specific IgM to TNP-Ficoll immunization
T ⇒ G
critical splice donor site
2 bp
probably benign
21
Rc3h1
0.262
sanroque
1
160906418-160974978 bp (+)
160940830
Unknown
no linkage results
2016-05-13
Peter Jurek
autoimmunity
immune system
T ⇒ G
synonymous
probably benign
22
Cryaa
0.000
L1n
17
31677933-31681724 bp (+)
31681025
Unknown
no linkage results
2016-05-13
Stephen Lyon
vision/eye
T ⇒ G
missense
probably damaging
1.000
[records 1 to 22 of 22]